Journal of Inorganic and Organometallic Polymers and Materials, Journal Year: 2024, Volume and Issue: unknown
Published: July 29, 2024
Language: Английский
Journal of Inorganic and Organometallic Polymers and Materials, Journal Year: 2024, Volume and Issue: unknown
Published: July 29, 2024
Language: Английский
Coordination Chemistry Reviews, Journal Year: 2024, Volume and Issue: 519, P. 216091 - 216091
Published: July 30, 2024
Wells-Dawson polyoxometalates (WD POMs) are an important subgroup within the diverse family of POMs. In last two decades, there has been remarkable progress in structure modification and post-functionalization WD POMs, which unlocked their enormous potential across various domains, including energy materials, catalysis (photocatalysis, electrocatalysis), functional materials (sensors, optical electrochromic magnetic materials) or biology/medicine (anticancer antibacterial activities). What makes these systems particularly captivating is highly adaptable topological structure, combined with versatile functionalization methods consequently precise design control, transfers into a wide range applications. our comprehensive review, we focus on exploration intricate structural characteristics play pivotal role properties. Moreover, exciting promising applications POMs areas science disciplines highlighted. Our aim to shed light current state art, identify emerging trends, provide insights future directions POM research, still being expanded, especially given rapid development continuous novel subunit functionalities. By doing so, hope contribute better understanding inspire further innovation utilization.
Language: Английский
Citations
8Dalton Transactions, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Recent advances in polyoxometalate (POM)-based materials with biomedical applications indicate significant potential the therapeutic field. The scientific community aims to advance these enhance bioorthogonal chemistry of POMs.
Language: Английский
Citations
1Inorganic Chemistry Frontiers, Journal Year: 2024, Volume and Issue: 11(14), P. 4439 - 4448
Published: Jan. 1, 2024
A tumor microenvironment-specifically activated POM@MOF was developed for PTT/CDT combination therapy against cells.
Language: Английский
Citations
6Molecular Catalysis, Journal Year: 2024, Volume and Issue: 567, P. 114456 - 114456
Published: Aug. 20, 2024
Language: Английский
Citations
4Coordination Chemistry Reviews, Journal Year: 2024, Volume and Issue: 524, P. 216304 - 216304
Published: Nov. 8, 2024
Language: Английский
Citations
4Published: Jan. 1, 2025
Language: Английский
Citations
0Talanta, Journal Year: 2025, Volume and Issue: 291, P. 127890 - 127890
Published: March 3, 2025
Language: Английский
Citations
0Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 162335 - 162335
Published: April 1, 2025
Language: Английский
Citations
0International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 282, P. 137381 - 137381
Published: Nov. 7, 2024
Language: Английский
Citations
1International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(5), P. 2569 - 2569
Published: Feb. 22, 2024
Polyoxotungstate nanoclusters have recently emerged as promising contrast agents for computed tomography (CT). In order to evaluate their clinical potential, in this study, we evaluated the vitro CT imaging properties, potential toxic effects vivo, and tissue distribution of monolacunary Wells–Dawson polyoxometalate, α2-K10P2W17O61.20H2O (mono-WD POM). Mono-WD POM showed superior X-ray attenuation compared other tungsten-containing (its parent WD-POM Keggin POM) standard iodine-based agent (iohexol). The calculated linear slope mono-WD was significantly higher WD-POM, POM, iohexol (5.97 ± 0.14 vs. 4.84 0.05, 4.55 0.16, 4.30 0.09, respectively). Acute oral (maximum-administered dose (MAD) = 960 mg/kg) intravenous administration (1/10, 1/5, 1/3 MAD) did not induce unexpected changes rats’ general habits or mortality. Results blood gas analysis, CO-oximetry status, levels electrolytes, glucose, lactate, creatinine, BUN demonstrated a dose-dependent tendency 14 days after POM. most significant differences control were observed MAD, being approximately seventy times than typically used (0.015 mmol W/kg) tungsten-based agents. highest tungsten deposition found kidney (1/3 MAD—0.67 0.12; 1/5 MAD—0.59 0.07; 1/10 MAD—0.54 0.05), which corresponded detected morphological irregularities, electrolyte imbalance, increased levels.
Language: Английский
Citations
0